NASDAQ
China Shineway Pharmaceutical Group Limited (CSWYF) has a revenue compound annual growth rate of 52.12% over 5 years and 25.36% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.